Business Description
Conformis Inc
NAICS : 339112
SIC : 3841
ISIN : US20717E1010
Description
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.99 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | -0.75 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -12.46 | |||||
| Beneish M-Score | -2.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -34.2 | |||||
| 3-Year EBITDA Growth Rate | 9.4 | |||||
| 3-Year EPS without NRI Growth Rate | 14 | |||||
| 3-Year FCF Growth Rate | -47.5 | |||||
| 3-Year Book Growth Rate | 7.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | -16.12 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.17 | |||||
| 9-Day RSI | 57.25 | |||||
| 14-Day RSI | 58.92 | |||||
| 6-1 Month Momentum % | 25.68 | |||||
| 12-1 Month Momentum % | -69.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.07 | |||||
| Quick Ratio | 3.3 | |||||
| Cash Ratio | 2.43 | |||||
| Days Inventory | 176.53 | |||||
| Days Sales Outstanding | 58.44 | |||||
| Days Payable | 49.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38.6 | |||||
| Shareholder Yield % | 8.08 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.21 | |||||
| Operating Margin % | -71.01 | |||||
| Net Margin % | -72.73 | |||||
| FCF Margin % | -81.91 | |||||
| ROE % | -78.18 | |||||
| ROA % | -44.56 | |||||
| ROIC % | -115.81 | |||||
| ROC (Joel Greenblatt) % | -125.22 | |||||
| ROCE % | -49.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.29 | |||||
| PB Ratio | 0.56 | |||||
| Price-to-Tangible-Book | 0.56 | |||||
| EV-to-EBIT | -0.47 | |||||
| EV-to-EBITDA | -0.52 | |||||
| EV-to-Forward-EBITDA | -0.06 | |||||
| EV-to-Revenue | 0.32 | |||||
| EV-to-Forward-Revenue | 0.34 | |||||
| EV-to-FCF | -0.39 | |||||
| Price-to-Net-Current-Asset-Value | 0.94 | |||||
| Earnings Yield (Greenblatt) % | -212.77 | |||||
| FCF Yield % | -286.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conformis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 54.376 | ||
| EPS (TTM) (€) | -5.377 | ||
| Beta | 0 | ||
| Volatility % | 120.26 | ||
| 14-Day RSI | 58.92 | ||
| 14-Day ATR (€) | 0.048162 | ||
| 20-Day SMA (€) | 2.0215 | ||
| 12-1 Month Momentum % | -69.51 | ||
| 52-Week Range (€) | 0.973 - 7.01 | ||
| Shares Outstanding (Mil) | 7.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conformis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conformis Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Conformis Inc Frequently Asked Questions
What is Conformis Inc(STU:3080)'s stock price today?
The current price of STU:3080 is €2.05. The 52 week high of STU:3080 is €7.01 and 52 week low is €0.97.
When is next earnings date of Conformis Inc(STU:3080)?
The next earnings date of Conformis Inc(STU:3080) is 2024-08-08 Est..
Does Conformis Inc(STU:3080) pay dividends? If so, how much?
Conformis Inc(STU:3080) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers